Prerpints.org logo
Preprint
Review

This version is not peer-reviewed.

Sodium Values During the First 10 Postnatal Days in Extremely Low Birth Weight Infants and Long Term Neurocognitive Outcomes: A Systematic Review

Submitted:

01 February 2026

Posted:

03 February 2026

You are already at the latest version

Abstract
Purpose: To synthesize all existing literature on the association between sodium disturbances during the first 10 days of life in Extremely Low Birth Weight (ELBW) infants and the risk of developing severe intraventricular hemorrhage (IVH> grade 1) or long-term neurodevelopmental impairment. Methods: Applying systematic review (ID CDR42024622933) principles, five major databases were explored. Any study was included if reporting on ELBW infants, on serum sodium values within the first 10 postnatal days and related these to neurocognitive or neurodevelopmental outcomes. Results: Ten studies (13,276 infants) met inclusion criteria. Six studies evaluated the association between hypernatremia (>145 or >150mmol/L) and severe IVH, two reported a significant association. Among two studies studying hyponatremia (ranging <130 or <120mmol/L), one found a significant association with severe IVH. Evidence regarding sodium fluctuations (difference between the maximum and minimum serum sodium values) identified fluctuations >13 mmol/L as a strong risk factor for severe IVH, while another showed that glucose-corrected sodium fluctuations were independently associated with severe IVH. Long-term neurodevelopmental outcomes were reported in four studies; hyponatremia was significantly associated with hearing loss in one study (OR 5.6 (95% CI 1.1–27.8)), while another study reported that glucose-corrected sodium fluctuations were associated with neurodevelopmental impairment at 18–21 months, although significance disappeared after adjustment for confounding factors. Conclusion: This systematic review suggests a possible association between early sodium disturbances and adverse neurodevelopmental outcomes in ELBW infants, emphasizing the need for further high-quality, prospective studies, especially since sodium management can be modulated.
Keywords: 
extremely low birth weight infants
;  
sodium imbalances
;  
hyponatremia
;  
hypernatremia
;  
neurodevelopmental outcomes
;  
intraventricular hemorrhage
Subject: 
Medicine and Pharmacology  -   Pediatrics, Perinatology and Child Health

Introduction

Extremely Low Birth Weight (ELBW, birth weight <1000 grams) infants are at increased risk of mortality and morbidity. This conveys to both short- and long-term morbidities, including those affecting the central nervous system [1]. Despite marked improvements in mortality, these morbidity rates have not prominently improved [2]. Neurocognitive development is multifactorial and influenced by antenatal, perinatal, and postnatal factors [1]. Electrolyte imbalances have been proposed as a potential contributing factor. Dysnatremia, either hyponatremia, hypernatremia or sodium fluctuations, are associated with several common complications in preterm infants [3]. Studies have also indicated that neonatal dysnatremia may influence neurocognitive outcomes, partly due to its relationship with IVH development [4,5,6]. A potential pathophysiological mechanism underlying this association involves fluid shifts, driven by osmolar changes. Neonates are particularly sensitive to such shifts due to immaturity of their brain’s adaptive mechanisms [7]. To provide a contemporary overview on the topic, we conducted a systematic review to synthesize the data from studies examining the relationship between sodium values during the first 10 days after birth and long-term neurocognitive outcomes and IVH in ELBW infants.

Methods

Registration and ethics
The protocol was registered in PROSPERO (ID CDR42024622933, December 19th, 2024). Ethics approval was obtained from the Ethics Board of KU Leuven, Belgium (MP034156) on November 28, 2024.
Search strategy
We conducted a comprehensive search across the following databases: PubMed, Embase, Web of Science Core Collection, Scopus, and CINAHL. The search was performed to include any study available in these databases up to December 5, 2024. No filters were applied. The search strategy was developed using predefined keywords related to ELBW infants and serum sodium levels, with expert input from an expert data scientist (Biomedical Librarian, Ms. Krizia Tuand, KU Leuven). A detailed overview of the search strategy, including the free-text terms used, is provided in Online Resource 1. The Covidence platform was used for the collection of data and analysis [8]. This systematic review was conducted in accordance with the principles outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [9].
Study selection criteria
Studies were eligible for inclusion if they met the following criteria: reporting on cases or cohorts of ELBW (i.e. birth weight <1000 grams) infants, with data on serum sodium values within the first 10 days of life, with subsequent reporting on neurocognitive or neurodevelopmental outcomes. Only studies published in English were included. We excluded studies involving ELBW infants with congenital conditions that could affect neurodevelopment or those with brain injury at birth.
After deduplication, two independent reviewers (S.B., K.A.) screened titles and abstracts for relevance. Full-text articles of potentially relevant studies were retrieved and were subsequently reassessed based on the selection criteria outlined. In cases of disagreement, a third independent reviewer (A.R.) was consulted to solve discrepancies. Finally, the reference lists of all retained articles were checked for other relevant articles.

Results

Structured Literature Review

After the screening process, 10 studies met inclusion criteria. The PRISMA flow diagram (see Figure 1) provides a detailed overview of the selection procedure [9].
Baseline characteristics
The studies included varied considerably in their design, sample size and participants’ demographics, and employed various inclusion and exclusion criteria. Table S1 (see Online Resource 2) summarizes the baseline characteristics of included studies. A total of 13,276 ELBW infants were analysed across studies.
The mean gestational age of included infants across studies ranged from 24 to 28 weeks. The mean birth weight varied, ranging from 520 to 982 grams. Data on sex ratio was available for 13,047 infants in total, 6308 (48,3%) were male, and 6739 (51,7%) were female, showing a rather balanced gender distribution.
Table S1 Baseline characteristics of included studies (see Online Resource 2)
Exposure
Data on sodium disturbances, a summary of definitions, timing of monitoring, incidence of sodium disbalance, and trends in sodium concentrations across the studies can be found in Table S2 (see Online Resource 3). Exposure variables measured varied between studies.
The most common form of dysnatremia studied was hypernatremia (n=8 studies) [3,4,6,10,11,12,13,14], followed by hyponatremia (n=3) [3,6,11]. Serum sodium fluctuations were examined in five studies [4,5,6,14,15]. In one study plasma sodium levels were corrected for glucose levels using the Katz formula (Na(corr) = Na + 0.3 x (Glucose -5) (mmol/L)) [15]. Definitions on threshold sodium values were not standardized. Several studies also assessed different severity categories of dysnatremia. Monnikendam et al. differentiated moderate (145–154 mmol/L) from severe hypernatremia (>154 mmol/L) and moderate (125–134 mmol/L) from severe hyponatremia (<125 mmol/L) [3]. Späth et al. categorized hypernatremia into three distinct levels (>145 mmol/L, >150 mmol/L, and >155 mmol/L), allowing for nuanced analyses of severity effects [14]. Across the various cohorts of ELBW infants, the incidence of hypernatremia showed considerable variability, ranging from 5.3% to 75.7%. Hyponatremia was assessed less frequently and presented with lower incidences, ranging from 2.3% to 35.1%.
The duration of serum sodium monitoring ranged from 3 to 10 days, reflecting the postnatal age interval of interest. In all studies, the initial measurement occurred within the first 24 hours of life. Sodium levels were measured at least once daily in all studies, with some studies performing measurements up to every 12 hours. Four studies reported on postnatal sodium trends. Findings were consistent across three studies, observing that sodium levels typically peaked around 48 hours of life and returned to baseline between day 4-7 [3,4,12,15]. In contrast, Dalton et al. found that maximum serum sodium occurred later, on mean postnatal day 4 [4].
Table S2 Exposure (sodium-related data) of included studies (see Online Resource 3)
Outcomes
Data on short term neurodevelopmental outcomes (severe IVH (>grade II), and long-term neurodevelopmental outcomes) can be found in Table S3 (see Online Resource 4). The included studies examining the association between severe IVH and sodium levels in ELBW infants consistently defined severe IVH as grade III-IV (Papile classification), detected by cranial ultrasound. The timing of IVH assessment typically ranged from day 1 to 10 of life. Although some studies did not specify exact timing, they indicated the use of routine cranial ultrasound, typically performed within this early postnatal period. Dalton et al. reported that the median day of onset was postnatal day 5 for any grade IVH, and day 4 for severe IVH [4].
The incidence of severe IVH among hypernatremic ELBW infants varied across studies. Monnikendam et al. assessed incidence between various dysnatremic subgroups. The highest incidence (28.9%) was seen in the severe hyponatremic group (<125 mEq/L), followed by the severe hypernatremic group (>154 mEq/L) (27.4%) [3]. Studies investigating the association between hypernatremia and severe IVH (n=6) found conflicting results. Four studies reported no significant association between hypernatremia and severe IVH [4,6,12,14]. Conversely, Monnikendam et al. demonstrated a significantly higher incidence of severe IVH in infants with both moderate and severe hypernatremia [3]. Additionally, Lim et al. observed significantly higher maximal sodium levels in infants with severe IVH compared to those without severe IVH, with mean sodium concentrations in the hypernatremic range. However, this did not remain significant after multivariate analysis [5].
In contrast, studies regarding hyponatremia were very limited (n=2). Monnikendam et al. demonstrated a significant association between both moderate and severe hyponatremia, and severe IVH, whereas Lee et al. found no significant differences in hyponatremia incidence between infants with severe IVH and those without [3,6].
The role of sodium fluctuations was examined across several studies (n=5) with varying conclusions. Two studies reported no significant associations between sodium fluctuations and severe IVH [6,14]. Similarly, Dalton et al. found no significant relationship between rapid changes in sodium levels in hypernatremic infants and the composite outcome of severe IVH or death [4]. In contrast, Lim et al. reported changes in serum sodium of >13 mmol/L were a strong risk factor for developing severe IVH [5]. Additionally, Gervais et al. explored glucose-corrected sodium fluctuations specifically and found these fluctuations were significantly associated with severe IVH, independent of gestational age [15].
Long-term neurodevelopmental outcomes were evaluated less frequently across studies (n=4). Leslie et al. found hyponatremia to be significantly associated with an increased risk of SNHL, assessed at 8-10 months of corrected age [11]. This association persisted after multivariate analyses adjusting for family history for hearing impairment, maternal, and neonatal confounding factors. Finally, case reports from Saeed et al. and Sabir et al. illustrated that individual major hypernatremic (204 mmol/L and 199 mmol/L) events still resulted in subsequent normal long-term neurodevelopment [10,13].
Gervais et al. evaluated the association between sodium fluctuations (adjusted for glucose levels) and a composite neurodevelopmental impairment at 18–21 months corrected age. Initially, a significant association was found, independent of gestational age. However, this relationship lost statistical significance after adjusting for markers of neonatal illness severity (Score for Neonatal Acute Physiology) and exposure to NSAIDs used for patent ductus arteriosus treatment [15].
Table S3 Neurodevelopmental outcomes of included studies (see Online Resource 4)
Discussion
Applying a systematic review, we summarized all availableevidence on potential associations between dysnatremia or larger sodium fluctuations during the first 10 days of life in ELBW infants and neurocognitive outcomes, be it with inconsistent findings across studies.
Exploring the Mechanism related to Early Sodium Values and Neurodevelopment
A potential pathophysiological mechanism underlying this association involves fluid shifts, driven by osmolar changes. Neonates are particularly sensitive to such shifts due to the immaturity of their brain’s adaptive mechanisms [7]. Hypernatremia has been shown to cause brain shrinkage, potentially leading to vascular rupture/strain and subsequent intracerebral hemorrhages, venous sinus thrombosis, and/or infarction. In response, the brain adapts by generating ionogenic osmoles like taurine, which increase intracellular sodium concentrations and restore water balance. However, if hypernatremia is subsequently corrected too rapidly, this adaptive response can predispose to cerebral oedema [16]. Similarly, this mechanism likely also explains the fact that acute hyponatremia is a risk factor for cerebral oedema [7]. It is noteworthy that hyperglycemia often accompanies hypernatremia in preterm infants. Hyperglycemia also causes fluid shifts and has been identified as independent risk factor for neurodevelopmental impairment [15,17]
However, dysnatremia might merely represent overall illness severity or immaturity; factors known to be strongly associated with poor neurodevelopmental outcomes. Some of our results support this statement, as the relationship between dysnatremia and neurodevelopmental outcomes lost significance after adjustment for confounding factors [5,15]. This notion is supported by Becker et al., who showed that excessive sodium supplementation, rather than fluid load, was strongly associated with overall morbidity in ELBW infants. Their findings suggest that impaired sodium homeostasis may predominantly reflect underlying clinical instability and renal immaturity [18].
Comparative Impact of Hyponatremia, Hypernatremia, and Sodium Fluctuations on Neurodevelopment
Among the three categories—hyponatremia, hypernatremia, and sodium fluctuations—there is no clear pattern on which poses the greatest risk to neurodevelopment. However, some trends occur.
Hypernatremia is the most observed sodium disturbance in the first postnatal week. Several studies reported a common sodium pattern. These findings correspond closely to recent observations by van Sas et al. and Pace et al., who described sodium levels peaking on day 3, subsequently returning to baseline by the end of the first week [19,20]. The physiological rise in sodium concentrations during the initial postnatal days reflects fluid shifts occurring predominantly within the first 24 to 48 hours after birth, most pronounced in preterm neonates [21,22]. Despite prevalent, its direct relationship with adverse outcomes remains debated. Only one study in our review reported a significant association between hypernatremia and severe IVH [3], others failed to find an independent association once confounders were controlled [4,5,6,12,14]
Hyponatremia, since less frequently observed, has received less research attention. Monnikendam et al. found the highest incidence of severe IVH in infants with severe hyponatremia (<125 mmol/L), even higher than in those with severe hypernatremia [3]. Conversely, Lee et al. did not find any significant associations between hyponatremia and severe IVH, possibly due to small sample sizes or variable definitions [6]. However, Leslie et al. found significant associations between hyponatremia and SNHL, especially in ELBW infants [11]. While causality remains uncertain, hyponatremia may act as a surrogate marker for systemic illness or may contribute through osmotic mechanisms or ototoxic treatments like furosemide [23].
Our research proposes a possible correlation between substantial sodium fluctuations and severe IVH. Gervais et al. further demonstrated a significant association between glucose-corrected sodium variability and IVH, emphasizing the potential role of osmotic instability rather than absolute sodium values [15]. While some studies did not confirm such associations, differences in fluctuation definitions may have influenced outcomes. Importantly, these results highlight the need to define clinical thresholds.
The Heterogeneity in Study Findings
A key finding is the marked heterogeneity in study design, definitions, and timing of measurements. This partially explains the considerable differences observed in reported incidences among ELBW cohorts and complicates comparison and pooling of data. Pace et al. also observed this in a recent review, showing that the lack of standardized definitions represents a significant challenge for research in this field [20]. Measurement periods also varied significantly. Some studies analysed sodium trends over 3 days, others over 7 or 10 days. Differences in sampling windows may result in variable sensitivity for detecting associations.
The assessment of IVH was another point of inconsistency. While most studies included in our review focused on severe IVH diagnosed via cranial ultrasound, the timing of ultrasound screening and IVH detection was often imprecise. Although IVH typically occurs within the first 48–72 hours of life, most studies failed to report the exact day of diagnosis. Only Dalton et al. reported a median onset of severe IVH on day 4 [4]. Without precise timing, it becomes difficult to assess causality or temporal relationships between dysnatremia and IVH onset.
Major Research Gaps and Future Directions
Our review highlights several important gaps. First, there is a need for standardized definitions of hyponatremia, hypernatremia, and clinically relevant sodium fluctuations in neonatal populations. Without consensus, future studies will remain difficult to compare or interpret [24].
Second, future research should focus on temporal relationships, particularly the timing of sodium disturbances in relation to IVH onset. Prospective studies should aim to record daily sodium levels and correlate these with precisely timed cranial ultrasounds to assess causality.
Third, considering the osmolar changes as likely mechanism, studies should correct sodium levels for glucose to correct for osmolarity. The approach by Gervais et al. of correcting sodium levels for glucose has rarely been adopted in other studies, despite the known influence of both sodium and glucose on plasma osmolality. ELBW infants frequently experience hyperglycemia due to heightened stress responses, excessive glucose supplementation, and insulin insensitivity [25]. Several studies have identified fluctuations in glucose levels as independent predictors of neurological dysfunction [25,26]. Consequently, consistently correcting plasma sodium values for glucose may prove important in future research examining the relationship between sodium concentrations and neurodevelopmental outcomes.
Finally, more research is needed linking sodium disturbances directly to long-term neurodevelopmental outcomes in the cohort of ELBW infants. Studies should incorporate standardized developmental assessments, like the Bayley Scales, and adjust for known confounders including gestational age, illness severity, and cerebral injury. This is even more relevant, since sodium fluctuations can be influenced in early neonatal life.
Strengths and limitations
Our study should be interpreted within regards to its strengths and limitations. A notable strength of this review is the simultaneous consideration of both severe IVH and long-term neurodevelopmental outcomes, given the potential link between these two factors. Nevertheless, our study carries certain limitations, primarily related to the retrospective nature of the studies included and the overall low number of studies available for analysis. Furthermore, there is an inherent risk of confounding bias, although many studies attempted to address this through multivariate analyses. In our review, we identified numerous maternal, perinatal, and neonatal confounding variables affecting hypernatremic and hyponatremic infants. Our findings underscore the importance of adequately adjusting for these variables in future research. Additionally, most individual studies included in this review had limited sample sizes, potentially contributing to type II errors, and explaining why some studies failed to demonstrate significant associations between sodium levels and neurodevelopmental outcomes. Finally, causation cannot be established based on the existing evidence, emphasizing the necessity for larger prospective investigations.

Conclusions

This systematic review suggests a potential association between early-life sodium levels in ELBW infants and later neurocognitive outcomes. Although we cannot determine whether this relationship is causal or merely reflecting underlying disease severity, these findings underscore the importance of careful early fluid and sodium management in these infants.. Further research in this area is essential for both primary prevention as well as secondary prevention of impaired neurocognitive outcomes.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org. The following Online Resources accompany this article: Online Resource 1: Search strategy used in PubMed, Embase, Web of Science Core Collection, CINAHL, and Scopus (PDF); Online Resource 2: Table S1 Baseline characteristics of included studies; Online Resource 3: Table S2 Exposure (sodium-related data) of included studies; Online Resource 4: Table S3 Neurodevelopmental Outcomes of included studies.

Author Contributions

Sara Beyen, Karel Allegaert and Anke Raaijmakers contributed to the study conception and design. Sara Beyen drafted the first draft of the manuscript. Sara Beyen and Karel Allegaert conducted the systematic review, Anke Raaijmakers was 3rd assessor in case of conflicts. Thomas Salaets reviewed and edited the paper. All authors commented on previous versions of the manuscript. All authors read and approved of the final manuscript.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Institutional Review Board Statement

Approved by the Ethics Board of KU Leuven, Belgium (MP034156), on November 28, 2024.

Acknowledgments

The authors thank Ms. Krizia Tuand (Data Scientist, Biomedical Library, KU Leuven) for her assistance in developing the search strategy. Detlef Böckenhauer provided valuable input and insight to improve the manuscript.

Conflicts of interest

The authors declare no conflicts of interest.

References

  1. Rogers EE, Hintz SR. Early neurodevelopmental outcomes of extremely preterm infants. Semin Perinatol 2016;40:497–509. [CrossRef]
  2. Zayegh AM, Doyle LW, Boland RA, Mainzer R, Spittle AJ, Roberts G, et al. Trends in survival, perinatal morbidities and two-year neurodevelopmental outcomes in extremely low-birthweight infants over four decades. Paediatr Perinat Epidemiol 2022;36:594–602. [CrossRef]
  3. Monnikendam CS, Mu TS, Aden JK, Lefkowitz W, Carr NR, Aune CN, et al. Dysnatremia in extremely low birth weight infants is associated with multiple adverse outcomes. Journal of Perinatology 2019;39:842–7. [CrossRef]
  4. Dalton J, Dechert RE, Sarkar S. Assessment of association between rapid fluctuations in serum sodium and intraventricular hemorrhage in hypernatremic preterm infants. Am J Perinatol 2015;32:795–802. [CrossRef]
  5. Lim WH, Lien R, Chiang MC, Fu RH, Lin JJ, Chu SM, et al. Hypernatremia and grade III/IV intraventricular hemorrhage among extremely low birth weight infants. J Perinatol 2011;31:193–8. [CrossRef]
  6. Lee HJ, Lee BS, Do HJ, Oh SH, Choi YS, Chung SH, et al. Early sodium and fluid intake and severe intraventricular hemorrhage in extremely low birth weight infants. J Korean Med Sci 2015;30:283–9. [CrossRef]
  7. Marcialis MA, Dessi A, Pintus MC, Marinelli V, Fanos V. Hyponatremia and hypernatremia in the newborn: in medio stat virtus. Frontiers in Bioscience-Elite 2012, 4(1), 132-140 2012;4:132–40. [CrossRef]
  8. Covidence systematic review management software n.d. https://www.covidence.org (accessed March 11, 2025).
  9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372. [CrossRef]
  10. M A Saeed 1. Severe hypernatraemia in a very preterm infant 2006. [CrossRef]
  11. LESLIE G, KALAW M, BOWEN J, ARNOLD J. Risk factors for sensorineural hearing loss in extremely premature infants. J Paediatr Child Health 1995;31:312–6. [CrossRef]
  12. Gawlowski Z, Aladangady N, Coen PG. Hypernatraemia in preterm infants born at less than 27 weeks gestation. J Paediatr Child Health 2006;42:771–4. [CrossRef]
  13. Sabir H, Stannigel H, Mayatepek E, Hoehn T. Severe hypernatremia in an extremely low birth weight infant with subsequent normal neurological development. Neonatology 2010;97:90–2. [CrossRef]
  14. Späth C, Stoltz Sjöström E, Ågren J, Ahlsson F, Domellöf M. Sodium supply from administered blood products was associated with severe intraventricular haemorrhage in extremely preterm infants. Acta Paediatr 2022;111:1701–8. [CrossRef]
  15. Gervais AS, Luu TM, Viennet A, Milette AA, Vallée J, Cloutier A, et al. Neurodevelopmental consequences of early plasma sodium changes in very preterm infants. Pediatr Res 2022;92:1350–6. [CrossRef]
  16. Durrani NUR, Imam AA, Soni N. Hypernatremia in Newborns: A Practical Approach to Management. Biomed Hub 2022;7:55. [CrossRef]
  17. Zamir I, Stoltz Sjöström E, Ahlsson F, Hansen-Pupp I, Serenius F, Domellöf M. Neonatal hyperglycaemia is associated with worse neurodevelopmental outcomes in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed 2021;106:460. [CrossRef]
  18. Becker K, Becker H, Riedl-Seifert T, Waitz M, Jenke A. Excessive sodium supplementation but not fluid load is correlated with overall morbidity in extremely low birth weight infants. JPGN Rep 2024;5:50–7. [CrossRef]
  19. Sas S van, Pace M, Salaets T, Laenen A, Raaijmakers A, Allegaert K. Sodium Patterns and Their Variables in a Cohort of ELBW Infants in the First 10 Days of Life. Children 2025, Vol 12, Page 337 2025;12:337. [CrossRef]
  20. Pace M, van Sas S, Salaets T, Laenen A, Raaijmakers A, Allegaert K. Hypo- and Hypernatremia in Extremely Low Birth Weight Infants in the First 10 Days of Life: A Review. Children (Basel) 2025;12. [CrossRef]
  21. Hong J, Rha DW. The Long-Term Outcome and Rehabilitative Approach of Intraventricular Hemorrhage at Preterm Birth. J Korean Neurosurg Soc 2023;66:289–97. [CrossRef]
  22. Lorenz JM, Kleinman LI, Kotagal UR, Reller MD. Water balance in very low-birth-weight infants: relationship to water and sodium intake and effect on outcome. J Pediatr 1982;101:423–32. [CrossRef]
  23. Brown DR, Watchko JF, Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case-control study. Dev Med Child Neurol 1991;33:816–23. [CrossRef]
  24. Allegaert K, Hildebrand H, Singh K, Turner MA. The publication quality of laboratory values in clinical studies in neonates. Pediatr Res 2023;94:96–8. [CrossRef]
  25. Bermick J, Dechert RE, Sarkar S. Does hyperglycemia in hypernatremic preterm infants increase the risk of intraventricular hemorrhage? J Perinatol 2016;36:729–32. [CrossRef]
  26. van der Lugt NM, Smits-Wintjens VEHJ, van Zwieten PHT, Walther FJ. Short and long term outcome of neonatal hyperglycemia in very preterm infants: a retrospective follow-up study. BMC Pediatr 2010;10. [CrossRef]
Preprints 197090 g001
Figure 1. Flow diagram of structured literature review according to the PRISMA guidelines.
Figure 1. Flow diagram of structured literature review according to the PRISMA guidelines.
Preprints 197090 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
bsky
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated